CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE

The application of simvastatine in arterial hypertension patients with metabolic syndrom corrects dislipoproteidemia, peroxidation syndrome, thrombocyte formation and optimized the thrombocyte hemostasis. Simvastatine inhibits decreased adhesive and aggregative function of thrombocytes. For stabiliz...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. J. Gromnazky, J. N. Medvedev, B. M. Golikov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2003-12-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension metabolic syndrome thrombocytes simvastatine
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1871
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

STATE CONTROL OF THE VASCULAR WALL TO ANTIAGGREGATIVE BY NEUTROPHILS IN PATIENTS ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA PATIENTS TREATED WITH SIMVASTATIN
by: I. N. Medvedev, et al.
Published: (2013-03-01)

Correction of endothelial dysfunction and microcirculation disturbances in patients with essential arterial hypertension and Type 2 diabetes mellitus
by: N. V. Yakutina
Published: (2007-12-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2006-10-01)

Effect of simvastatin on microinflammation in patients with uremia
by: SU Bo, et al.
Published: (2017-01-01)

Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-08-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
by: V. A. Nevzorova, et al.
Published: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
by: I. E. Chazova, et al.
Published: (2005-12-01)

ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT
by: V. N. Isakova, et al.
Published: (2016-01-01)

Verospiron effects on platelet aggregation in patients with arterial hypertension and abdominal obesity
by: I. N. Medvedev, et al.
Published: (2007-12-01)

Rapid normalization of platelet hemostasis in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-04-01)

COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

COMPARISON OF OPPORTUNITIES FROM TWO THERAPEUTICAL COMPLEXES FOR CORRECTION OF VASCULAR HEMOSTASIS IN HYPERTENSIVES WITH METABOLIC SYNDROME
by: S. Yu. Zavalishina, et al.
Published: (2017-04-01)

SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
by: I. S. Dzherieva, et al.
Published: (2015-12-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
by: A. N. Britov, et al.
Published: (2006-06-01)

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome
by: S. S. Yakushin, et al.
Published: (2004-12-01)

NonDpharmaceutical correction of intravascular platelet activity in hypertensive patients
by: I. N. Medvedev
Published: (2005-10-01)

POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN
by: I. V. Logacheva, et al.
Published: (2016-01-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
by: A. P. Vasilyev, et al.
Published: (2008-10-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01)

Simvastatin in primary and secondary prevention of cerebrovascular insufficiency
by: E. A. Melnik, et al.
Published: (2007-12-01)

FLUVASTATIN EFFECTS ON BLOOD CELL AGGREGATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2013-04-01)

The effect of use simvastatin at treatment of ischemic heart disease patients of senile age
by: A. L. Pirogov, et al.
Published: (2007-10-01)

EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01)

Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
by: O. A. Osipova, et al.
Published: (2022-10-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2015-09-01)

Metabolic disturbances and arterial hypertension in pregnancy: short- and long-term effects on mother and fetus
by: o. N. Tkacheva, et al.
Published: (1970-01-01)

Intima- media thickness of соmmоn carotid artery in patients with arterial hypertension and present or absent metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2008-12-01)

COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Simvastatin inhibits 20-Hydroxyeicosatetraenoic acid formation: docking and in vitro assay
by: Yazun Jarrar, et al.
Published: (2025-08-01)

Heart pathology in patients with arterial hypertension and metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2008-12-01)

THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE
by: V. V. Yakusevich, et al.
Published: (2015-12-01)

Renal pathology features in arterial hypertension patients with and without metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2008-12-01)

HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION
by: I. V. Osipova, et al.
Published: (2016-01-01)

Change in the fatty acids spectrum of erythrocyte in patients with chronic form of coronary heart disease in treatment by Simvastatin
by: V. V. Novitsky, et al.
Published: (2012-02-01)

Effect of different statins and EZETIMIBE/SIMVASTATIN on cardiovascular disease in patients with chronic kidney disease
by: ZHANG Xue-qing, et al.
Published: (2018-01-01)

Study of the Functional State of the Proximal Renal Tubules in Patients with Asymptomatic Chronic Heart Failure in Dyslipidemia and its Correction with Simvastatin Treatment
by: V. Yu. Kopylov
Published: (2020-12-01)

THE ROLE OF THE MATRIX METALLOPROTEINASES IN THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
by: A. N. Zakirova, et al.
Published: (2015-09-01)

Comparative effects of two therapeutic complexes on vascular wall activity in patients with arterial hypertension, metabolic syndrome, and recent ocular vessel occlusion
by: I. N. Medvedev, et al.
Published: (1970-01-01)

Severity of carbohydrate metabolism disturbances, arterial hypertension stage, and lipid profile in patients with metabolic syndrome
by: Yu. V. Zhernakova, et al.
Published: (2012-04-01)